In this article, we classified 1424 pMMR/MSS CRC patients into two classes, ‘immune cold’ and ‘immune hot’, based on the unsupervised clustering, and guanylate binding protein 2 (GBP2) was identified as a gene of interest. The gene discussed is GBP2; the disease is colorectal carcinoma.